Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ACLX-002 |
Trade Name | |
Synonyms | ACLX 002|ACLX002 |
Drug Descriptions |
ACLX-002 is a cell therapy comprising SPRX-002, a soluble protein targeting CD123, and Antigen Receptor Complex T-cells (ARC T-cells), which potentially induces antitumor activity (Cancer Res (2022) 82 (12_Supplement): 587). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ACLX-002 | ACLX-002 | 0 | 1 |